Table 1 Demographic and clinical characteristics of women with peripartum cardiomyopathy and cardiac outcomes
From: Breastfeeding in patients with peripartum cardiomyopathy: clinical outcomes and physician counseling
No Lactation | Lactation | p value (p < 0.05) | |
|---|---|---|---|
(n = 36) | (n = 18) | ||
Age at diagnosis (yrs) | |||
Mean ± SD | 31 ± 6 | 32 ± 6 | 0.56 |
African American Ancestry, n (%) | 8 (22) | 3 (17) | 0.73 |
Hypertension (pooled), n (%) | 21 (58) | 5 (28) | 0.12 |
Pre-Existing Hypertension, n (%) | 7 (19) | 3 (17) | 1.0 |
Gestational Hypertension, n (%) | 8 (22) | 1 (6) | 0.25 |
Preeclampsia, n (%) | 17 (47) | 4 (22) | 0.21 |
Gestational diabetes, n (%) | 2 (6) | 2 (11) | 0.57 |
Smoking, n (%) | 9 (25) | 4 (22) | 1.0 |
ACEi/ARB, n (%)* | 34 (94) | 14 (78) | 1.0 |
Beta Blocker, n (%)* | 32 (88) | 14 (78) | 1.0 |
Spironolactone, n (%)* | 18 (50) | 4 (22) | 0.21 |
Digoxin, n (%)* | 7 (19) | 5 (28) | 0.47 |
Diuretic, n (%)*† | 33 (92) | 12 (67) | 0.20 |
EF at diagnosis, mean ± SD | 28 ± 13 | 30 ± 13 | 0.59 |
EF at 12 months, mean ± SD | 39 ± 16 | 41 ± 15 | 0.65 |
Recovered, n (%) | 13 (36) | 4 (22) | 0.48 |